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INTRODUCTION
Up to now over 400 syndromic forms of hearing loss (HL) have 
been described [1]. Pendred syndrome (PS) (MIM#274600) is 
one of the most frequent types of syndromic HL, although it 
may remain underdiagnosed due to the late onset (usually after 
the second decade of life) and reduced penetrance of some of 
its common clinical features, especially the goiter. Over 90% of 
PS is caused by SLC26A4 mutations in different populations [2]. 
 SLC26A4 has been known by Everett et al. [3] using posi-
tional cloning and mapped on 7q22-31.1. This gene produces a 
5 Kb transcript and a 86 kDa protein with 780 amino acids, 
called pendrin, which is a member of solute carrier family 26A 
(SLC26A). 
 SLC26A4 mutations result in both PS and non syndromic HL 
(DFNB4; MIM#600791). These disorders have autosomal reces-
sive inheritance [2,4]. Similar HL severity and inner ear malfor-
mations ranging from enlarged vestibular aqueduct (EVA), the 
most frequent radiological abnormality in sensorineural HL (SN-
HL), to Mondini dysplasia (MD), a condition that normal co-
chlear spiral is 1.5 turns instead of 2.5 turns, are seen in both of 
them. EVA and MD are detectable with computed tomography 
(CT) [5]. The major difference between the two disorders is thy-
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roid abnormality (goiter) which is observed to be segregating 
with PS [2]. To date, more than 200 mutations have been identi-
fied for SLC26A4 (http://www.healthcare.uiowa.edu/labs/pen-
dredandbor/slcMutations.htm). 
 While GJB2 is responsible for up to half of autosomal reces-
sive nonsyndromic HL (ARNSHL) in Mediterranean, most Eu-
ropean and north American populations [6-8], this gene accounts 
for only 18.29% and/or 16.7% of Iranian families with HL [9, 
10]. In contrast, SLC26A4 appears to have a more crucial role 
in the etiology of hearing impairment (HI) in Asian than non-
Asian populations. About 7.2% of prelingual HL in Pakistan 
and 5% of this disease in east and south Asia happens due to 
SLC26A4 mutations [11,12]. Results of a former study suggest 
that SLC26A4 could be considered as the second cause of HI, 
after GJB2, in Iran [13].
 In addition to frequency, the type of SLC26A4 mutations is 
also different among populations. While IVS7-2A>G and H723R 
are the most frequent SLC26A4 mutations in east Asia, R79X 
and R409H are more common in the Iranian HL population 
[13-15]. Epidemiological data regarding ethnic and population 
specificity of SLC26A4 mutations could be beneficial for diag-
nosis, clinical decision-making, family planning as well as de-
signing cost-effective strategy for molecular testing. 
 In the present investigation, a large deaf Iranian kindred with 
9 patients was subject to genetic linkage analysis and two novel 
mutations were identified.
MATERIALS AND METHODS
Subjects
The research was approved by the Institutional Review Boards 
of Shahrekord University of Medical Sciences. We studied a large 
consanguineous family Iranian 3 (IR3), including 9 patients with 
hereditary HL from Fars province of Iran, with no GJB2 muta-
tion in our previous research [9]. There were four consanguinity 
loops in the pedigree: subjects III-1 and III-2, IV-3 and IV-4, IV-
18 and IV-19, and individuals III-7 and III-8 had first cousin 
marriages (Fig. 1). We also recruited 100 healthy matched con-
trols from the same ethnic background. Written informed con-
sent was obtained from all the subjects or their parents.
Phenotype evaluation
Audiological testing
For measurement of hearing, all patients underwent pure tone 
audiometry (PTA) test for air conduction at a range of frequen-
cies from 250 to 8,000 Hz. Audiogram results of all patients were 
defined using a PTA average at three frequencies (500, 1,000, 
2,000 Hz): mild for 21-40 dB, moderate for 41-70 dB, severe for 
71-95 dB and profound for >95 dB. 
Thyroid phenotype testing
The phenotype of thyroid was investigated with evaluation of its 
structure, size and function, based on sex and age of patients. 
Fig. 1. Pedigree and haplotypes of the family Iranian 3 (IR3). The order of markers is based on the Marshfield map. The homozygous haplotype 
of part A was different from that of part B of the pedigree. Variants c.881-882delAC and c.863-864insT were found in part A and B, respective-
ly. Patient VI-1 had both haplotypes simultaneously which were later shown to carry c.881-882delAC and c.863-864insT mutations (compound 
heterozygosity).
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Ultrasonography with Sonoline G50 ultrasound system (Sie-
mens Medical Solutions, Erlangen, Germany) was applied to 
identify thyroid size and structure for all patients. For functional 
analysis of thyroid in all patients, thyroid stimulated hormone 
(TSH), thyroxin (T4), and triiodothyronine (T3) levels were mea-
sured by means of a chemiluminescent immunoassay (Berthold 
Technology-CSA, Bad Wildbad, Germany). 
CT scan of temporal bone 
All patients except V-5 and V-2 underwent high resolution CT 
scan by Somatom Sensation Emotion 16-Slice Configuration 
(Siemens Medical Solutions) for examination of vestibular aque-
duct. EVA was defined as the diameter at the midway between 
the common crus and the external aperture being equal or more 
than 1.5 mm [16].
Molecular studies 
DNA extraction 
Genomic DNA for all available members of the pedigree as well 
as 100 ethnically matched normal control persons was prepared 
from 500 μL of peripheral blood by a standard phenol chloro-
form protocol [17]. For evaluation of quantity and quality of ex-
tracted DNA, spectrophotometry (UNICO 2100, West Spring-
field, MA, USA) and agarose gel electrophoresis were carried 
out according to routine methods. 
Slink calculation, DFNB4 STR marker genotyping and linkage analysis
Selection of four short tandem repeat (STR) markers (D7S2456, 
D7S2459, D7S496, and D7S2420) and their primers were 
based on their physical distance, available at NCBI UniSTS and 
NCBI map viewer (http: //www.ncbi.nlm.nih.gov/mapview). 
 Slink value was obtained by FastSlink ver. 2.51 option of Easy-
Linkage ver. 5.05 [18]. Polymerase chain reaction (PCR) ampli-
fication of STR markers was performed as follow: 1 μL of MgCl2 
(50 mM), 2.5 μL of Taq PCR buffer (10X), 0.4 μL of each of the 
primers (10 pM), 0.5 μL of dNTP mix (10 mM), 0.1 μL Taq 
DNA polymerase (5 U/μL), 2 μL DNA (50 ng), adjusted to 25 
μL using ddH2O. For various primers some modifications were 
applied. 
 For amplification, the following touch-down PCR program 
was used: an initial denaturation at 95°C for 5 minutes, followed 
by six cycles of 95°C for 50 seconds (denaturation), 58°C for 50 
seconds in the first cycle with 1°C reduction per cycle (anneal-
ing), and 72°C for 50 seconds (extension) and 32 cycles of 95°C 
for 50 seconds (denaturation), 53°C for 50 seconds (annealing), 
72°C for 50 seconds (extension) and a final extension at 72°C 
for 8 minutes. PCR products were loaded on a 14% polyacryl-
amide gel electrophoresis (PAGE) and run at 28 mA for 2-8 
hours. Silver staining was performed to visualize the bands on 
the gel following standard protocols.
 Two-point and multi-point logarithm of odds (LOD) scores 
were calculated by SuperLink ver. 1.6), and SimWalk ver. 2.91 
options of EasyLinkage ver. 5.05, respectively [18,19]. STR 
markers haplotypes were reconstructed by SimWalk and visual-
ized using Haplopainter ver. 029.5 software after linkage analy-
sis [20]. Autosomal recessive (AR) mode of inheritance, com-
plete penetrance, disease-allele frequency of 0.001, existence of 
no phenocopy, equal allele frequencies for markers and identical 
meiotic recombination frequencies in both sexes were assumed 
for LOD score calculations.
Mutation screening of SLC26A4 
All 21 exons (including 50-200 bp flanking regions) and pro-
moter of SLC26A4 were amplified using primers designed by 
Oligo ver. 6.7.1.0 (National Biosciences Inc., Plymouth, MN, 
USA) (Table 1).
 Amplification was performed, with some modifications for 
each amplicons, in a 50 μL volume of reaction, containing 4 μL 
of MgCl2 (50 Mm), 5 μL of Taq PCR buffer (10X), 0.6 μL of each 
primer (10 pM), 1 μL of dNTP mix (10 mM), 0.2 μL Taq DNA 
pol (5 U/μL), 4 μL DNA (50 ng), 34.6 of ddH20. PCR was done 
according to the following program: an initial denaturation at 
95°C for 5 minutes, 36 cycles of 95°C for 1 minute (denatur-
ation), 61°C for 1 minute (annealing), 72°C for 1 minute (exten-
sion) and a final extension at 72°C for 8 minutes. DNA sequenc-
ing of the PCR-amplified product was performed bi-directional-
ly on an ABI 3730XL automated sequencer (Applied Biosys-
tems, Macrogen, Seoul, Korea) using the same primers for am-
plification.
Pathogenicity investigation of novel variants
Mutation confirmation was done with co-segregation study of 
the novel variants and their absence in 100 ethnically matched 
normal control subjects. For investigation of c.881-882delAC 
variant pathogenicity, a 89 bp fragment of exon 7 harbouring 
c.881-882delAC location was amplified with primers 7K1F and 
7K1R. For studying c.863-864insT pathogenicity, a 44 bp frag-
ment of exon 7, containing the location of this variant, was am-
plified using 7K2F and 7K2R primers. 7K1 and 7K2 primers 
were designed by primer3 ver. 0.4.0 (http://frodo.wi.mit.edu/
primer3/) and Oligo ver. 6.7.1.0 (National Biosciences Inc.), re-
spectively (Table 1). PCR amplifications were performed using 
the conditions mentioned above. Amplification products were 
run on 14% PAGE at 28 mA for 3 hours. Allelic variant c.881-
882delAC is 2 bp shorter than wild type alleles and c.863-864-
insT is 1bp longer than normal type alleles.
RESULTS
Phenotype evaluation results
Audiological testing results
Audiological characterization of all patients is shown in Fig. 2. 
Mean PTA of thresholds for air conduction at frequencies 500, 
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Table 1. SLC26A4 primers for amplification of promoter (P), 21 exons, a 89 bp (7k1) and a 44 bp fragments (7k2) of exon 7
Primer name Sequence (5´  3´) Primer name Sequence (5´  3´) PCR product length (bp)
F1 CTGGCCATTGTTCCTCTT R1 TTGAGCAAGTCTCTCCCC 618
F2 ACTCGCTTCAAGTTTGGG R2 GCGAGTTTCCCAGGTAAG 664
F3 GCACTTCAGGGTTATTATTTTC R3 AAGAGAACTCTAAGGAAGGGG 461
F4 GAAAAACAGAATGGTTGTATGG R4 GAAAAAGCAGGCAAAACAC 496
F5 GATGGGGTTTTACTATGTTGC R5 CTCTCATCCTCAATTGAATCAC 689
F6 ATTTTTGTGCTATAGGCAGG R6 ATGAGGTCTCACGTCTCAAA 459
F7 ATCACCCAGTTTTTCCTTTC R7 GGGATGGATTTAACAATGC 595
F8 ATAGACGCTGGTTGAGATTTT R8 AGAAAAAAGAGCATATACGGG 558
F9 CAGCCAGTAAGATAACACCAA R9 AAAGCAAAGTGATGCAGTGT 538
F10 TTATCGAGAGCAATGAGACC R10 TCAGTTGTTATTGACCACAGC 606
F11 TAGATGCCATTTTTGTTCAGTT R11 ACACAGCTGCATAAACATCC 468
F12 CATCTCTGCTGCGATTGT R12 CCAAAGGTGTATGAATGAGC 556
F13 AATCCAGAAGATGGAGGC R13 AAATCTTAGCTCTGCCACG 593
F14 CCAGCTGTTCATTTCAGAGT R14 AAAAGTTTTCATGACACTCCC 378
F15 ACTGTGACTTGACTCCTTGC R15 TTTAATTCTCATTGCCCTACAC 321
F16 TTGTCTTTTACTGTCTTGGAGC R16 TTGCACTTATTTTGTTCCTTTC 626
F17 CACAATCATCCAGAAAACAAA R17 CAGATTAAGCAACTTGCCC 689
F18 CTGGATGTTGCCATCTCTT R18 CTGTCTTTGGCCTTTTCTG 496
F19 TAGGGTGTGCCCTGTAGTC R19 TACACAAATCCCAGATCACAA 676
F20 CAGAGGGGGTGACTTGTTA R20 TAGGTATCAAATCAGGAGCAGT 628
F21 GGGCAACAGTGAGTGAGAT R21 GTGATGTAGATCAGCAGCGT 494
FP TGGGGAGGAGTTCTGAGT RP ATCCTCACTCATCCCGTT 715
F7K1 TGCTCACCATTGTCGTCTGT R7K1 AATTACTTCTATAGGAATAGGGACTGG   89
F7K2 GTCGTCTGTATGGCAGTT R7K2 TGTCTAAACCGATCATTT   44
Fig. 2. Mean audiometric hearing thresholds for right and left ears of all patients of part A (triangles), patients V-3 and V-5 of part B (squares), 
and audiogram of both ears of patient VI-1 (circles) of the family Iranian 3. 
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1,000, 2,000 Hz was 97.22±7.09 for part A, 90.83±5.20 for 
part B, 60±5 for patient VI-1 (right ear) and 95.83±5 for part A, 
86.67±5.20 for part B and 46.67±2.89 for patient VI-1 (left ear). 
The severity of HL for all patients has been shown in Table 2.
Thyroid phenotype testing results
All patients had multinodular goiter and normal level of T3, T4, 
and TSH hormones (euthyroid goiter), except VI-1, who had a 
normal size thyroid and normal levels of thyroid hormones (Ta-
ble 2, Fig. 3) 
CT scan of temporal bone 
Vestibular aqueduct enlargement was observed in all the patients 
assayed for temporal bone in the present study. MD was also de-
tected in three of the patients inspected (Table 2, Fig. 4).
Molecular studies results
Slink calculation, DFNB4 STR marker genotyping and linkage analysis
Slink, two-point and multi-point LOD scores were respectively 
as follows: 4.90, 5.17, and 6.57 (Fig. 5). LOD score >3 confirm-
ed linkage to DFNB4. 
Yazdanpanahi N et al.: Novel SLC26A4 Mutations in Iranian Patients with Pendred Syndrome    205
Table 2. Clinical and genetic evaluation results of all patients of the family Iranian 3
ID no.
Age 
(year)
Sex
Audiogram of 
both ears
CT scan
Thyroid (T3, T4) and  
TSH hormones
Thyroid 
ultrasonography 
Variant
Homozygous or  
Heterozygous
V-2 19 M Profound NA Normal Multinodular goiter c.881-882del AC Homozygous
IV-4 46 M Profound EVA, MD Normal Multinodular goiter c.881-882del AC Homozygous
IV-5 40 M Severe EVA Normal Multinodular goiter c.881-882del AC Homozygous
IV-8 31 M Severe EVA Normal Multinodular goiter c.881-882del AC Homozygous
IV-9 30 F Profound EVA Normal Multinodular goiter c.881-882del AC Homozygous
V-3 32 M Profound EVA, MD Normal Multinodular goiter c.863-864insT Homozygous
V-5 22 F Severe NA Normal Multinodular goiter c.863-864insT Homozygous
VI-1 8 F Moderate EVA Normal No goiter c.863-864insT/ 
c.881-882del AC
Compound 
   heterozygous
CT, computed tomography; TSH, thyroid-stimulated hormone; EVA, enlarged vestibular aqueduct; MD, Mondini dysplasia; NA, not available. 
Fig. 3. Thyroid ultrasonography result of patient V-5 (from family Ira-
nian 3) with multinodular goiter. The arrows show nodules. The view 
is axial, and ultrasound probe is positioned in the neck region.
Fig. 4. Computed tomography scan of the temporal bone for patient IV-8 (from family Iranian 3) with bilateral enlarged vestibular aqueduct.
ence of both haplotypes in patient V1-1 predicted possible com-
pound heterozygosity (Fig. 1), which was later confirmed by DNA 
sequencing: two novel variants including c.863-864insT (p.Leu-
288PhefsX3) and c.881-882delAC (P.His294GlnfsX35) were 
identified in exon 7 of SLC26A4 (Fig. 6). Homozygous c.863-
864insT variant was found in Patients V-3 and V-5, while subjects 
V-4, V-7, IV-20, IV-19, IV-18, IV-17, IV-13, and IV-10 were het-
erozygous for this variant. Individuals II-4, III-1, III-2, III-3, IV-1, 
IV-2, and IV-3 were heterozygous for c.881-882delAC. Patients 
IV-4, IV-5, IV-8, IV-9, V-1, and V-2 were homozygous for this vari-
ant. Compound heterozygosity for both of these variants was 
revealed in patient VI-1. 
Pathogenicity confirmation of novel variants
The variants c.881-882delAC and c.863-864insT were found in 
a homozygous state in patients of the pedigree but were not de-
tected, or were in heterozygous state, in normal subjects of the 
family. None of these variants were detected in 100 ethnically 
matched normal control subjects. With respect to these results 
and the nature of the two variants (frameshift), we suggest the 
pathogenicity role of both variants.
Mutation screening of SLC26A4 results
Finding of two different homozygous haplotypes in the patients 
of part A and part B of the pedigree and the simultaneous pres-
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Fig. 5. Multipoint logarithm of odds (LOD) score calculation of the family Iranian 3 with SimWalk ver. 2.91 showed a score of 6.57 confirming 
linkage to DFNB4 locus.
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Fig. 6. Electropherogram results of two novel SLC26A4 variants in family Iranian 3 and normal alleles. (A) A patient with homozygous c.863-
864insT allele. (B) A normal subject without c.863-864insT allele. (C) A patient with homozygous c.881-882delAC allele. (D) A normal subject 
without c.881-882delAC allele.
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DISCUSSION
In the present study, we detected two novel variants (c.863-
864insT and c.881-882delAC) in a large consanguineous Iranian 
family with 9 patients with HL linked to DFNB4 locus. c.863-
864insT with a frameshift at codon 288 causes a premature stop 
at position 290 and c.881-882delAC results in a frameshift at 
codon 294 and a premature stop at position 328. 
 There is no definite structure for pendrin but a few models 
have been predicted for this protein. Based on pendrin structur-
al modeling, predicted by Everett et al. [3] and the model de-
scribed in Pendred/Bor homepage (http://www.healthcare.edu/
labs/pendredandbor/domains.htm), c.863-864insT and c.881-
882delAC lead to amino acid changes at intracellular region be-
tween the sixth and seventh transmembrane domains of the pro-
tein (Fig. 7). Thus, these variants can delete more than half of 
pendrin and cause a defective protein without a long C terminal 
segment which probably is not processed to reach the plasma 
membrane and would not be functional.
 However, further molecular studies on mRNA expression might 
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be necessary to help gain a more comprehensive understanding 
of the exact effect of these two novel variants on structure and 
function of the resulting protein. 
 In this study, patient VI-1, aged 8 years old, had normal thy-
roid size and function and a moderate HL. She was compound 
heterozygous for c.863-864insT and c.881-882delAC. The com-
bined presence of the two variants may lead to a different phe-
notype from that caused by any single variant alone in the ho-
mozygous state. Alternatively, PS-related phenotypes in the pa-
tient might be progressive and could be more severe with age. 
As goiter does not usually manifest until adulthood and even af-
ter that, the patient VI-1 may show goiter at an advanced age. 
Furthermore, according to Scott et al. [21] study, PS and DFNB4 
SLC26A4 mutations are different functionally. Mutations, lead-
ing to PS are usually associated with no transporting ability, but 
those accounting for DFNB4 HL may show some residual io-
dide and chloride transporting function. 
 However, no obvious relationship has been reported between 
SLC26A4 mutations and phenotype by some investigators [22, 
23]. These contradictory results could suggest that some other 
modifier genes, epigenetic and environmental factors such as 
nutritional iodide uptake can influence the clinical manifesta-
tions due to SLC26A4 mutations. Other patients in the pedigree 
had mostly severe to profound HL, and were positive for EVA 
and euthyroid goiter. These results show c.863-864insT and 
c.881-882delAC would most probably cause PS with rather 
similar phenotypic patterns.
 It has been suggested that SLC26A4 would play a more con-
siderable role in HI of Asian populations, such as Iranians, than 
other populations [11-15,24]. Up to now a considerable number 
of all mutations, which have been detected in Iranian HL pa-
tients have been novel [13,25,26]. In the present study, we de-
tected two different novel variants segregating with HL in a 
large deaf family. Taken together, these different studies probably 
confirm the high frequency and specificity of SLC26A4 muta-
tions and the critical role of these defects in causing HI in Irani-
an heterogenous population. Therefore it is beneficial to consid-
Fig. 7. c.863-864insT and c.881-882delAC variants which cause ami-
no acid change at intracellular region (most probably, between the 
sixth and seventh transmembrane domains) of the pendrin protein 
in the Everett model.
COOH
NH2 c.863-864insT c.881-882delAC
er screening of SLC26A4 mutations in molecular diagnostics of 
HL. Furthermore, Detection of mutations in this gene may have 
implications for better understanding of the exact structure and 
function of pendrin as well as designing of comfortable and 
more cost effective strategies in genetic diagnosis of HI. 
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